Malignant Digestive System Neoplasm — Trials

Malignant Digestive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

19,101 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,262
Recruiting: 2,363
Ph III recruiting: 292
Growth YoY: +13%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 28.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2,000)

clinicaltrialsPublishedShowing 151–200 of 285 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04130399	Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer	withdrawn	Phase 2	0	Indiana UniversityOTHER	1	Oct 17, 2019	clinicaltrials
NCT01524575	Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1	withdrawn	Phase 2	0	University of HawaiiOTHER	1	Sep 25, 2019	clinicaltrials